🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine efficacy of treatment with bortez...
Status
Completed
Location
Multiple Locations
Start Date
2009-01
Trial ID
NCT00872521
Treatments Being Tested
The purpose of this study is to evaluate time to progression, overall survi...
Status
Completed
Location
Multiple Locations
Start Date
2004-12
Trial ID
NCT00103506
Treatments Being Tested
The main objective of this study is to assess the long-term effectiveness o...
Status
Completed
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT00095680
Treatments Being Tested
The purpose of this study is to investigate the efficacy and safety of long...
Status
Completed
Location
Kameda Medical Center
Start Date
2018-02-18
Trial ID
NCT03416374
Treatments Being Tested
The purpose of this study is to compare a standard chemotherapy regimen of ...
Status
Unknown
Location
112 sites UK wide
Start Date
2010-05
Trial ID
NCT01554852
Treatments Being Tested
This is a Phase 1/2 study evaluating the safety and anti-tumor activity of ...
Status
Completed
Location
Northwestern Medical Faculty Foundation
Start Date
2008-01
Trial ID
NCT00555906
Treatments Being Tested
This phase I trial is studying the side effects and best dose of giving tan...
Status
Terminated
Location
Mayo Clinic
Start Date
2004-11
Trial ID
NCT00096005
Treatments Being Tested
Eligible participants with newly diagnosed myeloma who are not considered e...
Status
Recruiting
Location
Gundersen Lutheran
Start Date
2026-09
Trial ID
NCT07285239
Multiple myeloma is a malignant incurable hematological disease where survi...
Status
Completed
Location
Hæmatologisk afdeling B, Aalborg Sygehus Syd
Start Date
2005-12
Trial ID
NCT00417911
Treatments Being Tested
The trial is designed as a randomised, controlled, open, parallel group, mu...
Status
Completed
Location
Birmingham Heartlands Hospital
Start Date
2018-07-16
Trial ID
NCT06212596
Treatments Being Tested